Cargando…
The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
The data regarding the prognostic significance of EGFR (epidermal growth factor receptor) expression and adjuvant therapy in patients with resected pancreatic cancer are insufficient. We retrospectively investigated EGFR status in 357 resected PDAC (pancreatic duct adenocarcinoma) patients using tis...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964466/ https://www.ncbi.nlm.nih.gov/pubmed/27399694 http://dx.doi.org/10.3390/ijms17071090 |
_version_ | 1782445116767600640 |
---|---|
author | Guo, Meng Luo, Guopei Liu, Chen Cheng, He Lu, Yu Jin, Kaizhou Liu, Zuqiang Long, Jiang Liu, Liang Xu, Jin Huang, Dan Ni, Quanxing Yu, Xianjun |
author_facet | Guo, Meng Luo, Guopei Liu, Chen Cheng, He Lu, Yu Jin, Kaizhou Liu, Zuqiang Long, Jiang Liu, Liang Xu, Jin Huang, Dan Ni, Quanxing Yu, Xianjun |
author_sort | Guo, Meng |
collection | PubMed |
description | The data regarding the prognostic significance of EGFR (epidermal growth factor receptor) expression and adjuvant therapy in patients with resected pancreatic cancer are insufficient. We retrospectively investigated EGFR status in 357 resected PDAC (pancreatic duct adenocarcinoma) patients using tissue immunohistochemistry and validated the possible role of EGFR expression in predicting prognosis. The analysis was based on excluding the multiple confounding parameters. A negative association was found between overall EGFR status and postoperative survival (p = 0.986). Remarkably, adjuvant chemotherapy and radiotherapy were significantly associated with favorable postoperative survival, which prolonged median overall survival (OS) for 5.8 and 10.2 months (p = 0.009 and p = 0.006, respectively). Kaplan–Meier analysis showed that adjuvant chemotherapy correlated with an obvious survival benefit in the EGFR-positive subgroup rather than in the EGFR-negative subgroup. In the subgroup analyses, chemotherapy was highly associated with increased postoperative survival in the EGFR-positive subgroup (p = 0.002), and radiotherapy had a significant survival benefit in the EGFR-negative subgroup (p = 0.029). This study demonstrated that EGFR expression is not correlated with outcome in resected pancreatic cancer patients. Adjuvant chemotherapy and radiotherapy were significantly associated with improved survival in contrary EGFR expressing subgroup. Further studies of EGFR as a potential target for pancreatic cancer treatment are warranted. |
format | Online Article Text |
id | pubmed-4964466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-49644662016-08-03 The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer Guo, Meng Luo, Guopei Liu, Chen Cheng, He Lu, Yu Jin, Kaizhou Liu, Zuqiang Long, Jiang Liu, Liang Xu, Jin Huang, Dan Ni, Quanxing Yu, Xianjun Int J Mol Sci Article The data regarding the prognostic significance of EGFR (epidermal growth factor receptor) expression and adjuvant therapy in patients with resected pancreatic cancer are insufficient. We retrospectively investigated EGFR status in 357 resected PDAC (pancreatic duct adenocarcinoma) patients using tissue immunohistochemistry and validated the possible role of EGFR expression in predicting prognosis. The analysis was based on excluding the multiple confounding parameters. A negative association was found between overall EGFR status and postoperative survival (p = 0.986). Remarkably, adjuvant chemotherapy and radiotherapy were significantly associated with favorable postoperative survival, which prolonged median overall survival (OS) for 5.8 and 10.2 months (p = 0.009 and p = 0.006, respectively). Kaplan–Meier analysis showed that adjuvant chemotherapy correlated with an obvious survival benefit in the EGFR-positive subgroup rather than in the EGFR-negative subgroup. In the subgroup analyses, chemotherapy was highly associated with increased postoperative survival in the EGFR-positive subgroup (p = 0.002), and radiotherapy had a significant survival benefit in the EGFR-negative subgroup (p = 0.029). This study demonstrated that EGFR expression is not correlated with outcome in resected pancreatic cancer patients. Adjuvant chemotherapy and radiotherapy were significantly associated with improved survival in contrary EGFR expressing subgroup. Further studies of EGFR as a potential target for pancreatic cancer treatment are warranted. MDPI 2016-07-08 /pmc/articles/PMC4964466/ /pubmed/27399694 http://dx.doi.org/10.3390/ijms17071090 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Guo, Meng Luo, Guopei Liu, Chen Cheng, He Lu, Yu Jin, Kaizhou Liu, Zuqiang Long, Jiang Liu, Liang Xu, Jin Huang, Dan Ni, Quanxing Yu, Xianjun The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer |
title | The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer |
title_full | The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer |
title_fullStr | The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer |
title_full_unstemmed | The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer |
title_short | The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer |
title_sort | prognostic and predictive role of epidermal growth factor receptor in surgical resected pancreatic cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964466/ https://www.ncbi.nlm.nih.gov/pubmed/27399694 http://dx.doi.org/10.3390/ijms17071090 |
work_keys_str_mv | AT guomeng theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT luoguopei theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT liuchen theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT chenghe theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT luyu theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT jinkaizhou theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT liuzuqiang theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT longjiang theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT liuliang theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT xujin theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT huangdan theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT niquanxing theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT yuxianjun theprognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT guomeng prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT luoguopei prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT liuchen prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT chenghe prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT luyu prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT jinkaizhou prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT liuzuqiang prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT longjiang prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT liuliang prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT xujin prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT huangdan prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT niquanxing prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer AT yuxianjun prognosticandpredictiveroleofepidermalgrowthfactorreceptorinsurgicalresectedpancreaticcancer |